1. Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases.
Am J Surg Pathol 28:2004;505–513.
2. Matsuda O, Makiguchi K, Ishibashi K, Chida Y, Ida T, Matsuda K, Tomita K, Marumo F, Hiruma M. Long-term effects of steroid treatment on nephrotic syndrome associated with Kimura’s disease and a review of the literature.
Clin Nephrol 37:1992;119–123.
3. Rajpoot DK, Pahl M, Clark J. Nephrotic syndrome associated with Kimura disease.
Pediatr Nephrol 14:2000;486–488.
4. Katagiri K, Itami S, Hatano Y, Yamaguchi T, Takayasu S.
In vivo expression of IL‐4, IL‐5, IL‐13 and IFN‐γ mRNAs in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura’s disease.
Br J Dermatol 137:1997;972–977.
5. Enokihara H, Koike T, Arimura H, Aoyagi M, Watanabe K, Nakamura Y, Yamashiro K, Tsuruoka N, Tsujimoto M, Saito K. IL-5 mRNA expression in blood lymphocytes from patients with Kimura’s disease and parasite infection.
Am J Hematol 47:1994;69–73.
6. Lu HJ, Tsai JD, Sheu JC, Tzen CY, Tsai TC, Lin CC, Huang FY. Kimura disease in a patient with renal allograft failure secondary to chronic rejection.
Pediatr Nephrol 18:2003;1069–1072.
7. Connelly A, Powell HR, Chan YF, Fuller D, Taylor RG. Vincristine treatment of nephrotic syndrome complicated by Kimura disease.
Pediatr Nephrol 20:2005;516–518.
8. Sato S, Kawashima H, Kuboshima S, Watanabe K, Kashiwagi Y, Takekuma K, Hoshika A. Combined treatment of steroids and cyclosporine in Kimura disease.
Pediatrics 118:2006;e921–e923.
9. Chang AR, Kim K, Kim HJ, Kim IH, Park CI, Jun YK. Outcomes of Kimura’s disease after radiotherapy or nonradiotherapeutic treatment modalities.
Int J Radiat Oncol Biol Phys 65:2006;1233–1239.
10. Day TA, Abreo F, Hoajsoe DK, Aarstad RF, Stucker FJ. Treatment of Kimura’s disease: a therapeutic enigma.
Otolaryngol Head Neck Surg 112:1995;333–337.
11. Keven K, Nergizoğlu G, Ateş K, Erekul S, Orhan D, Ertürk Ş, Tulunay Ö, Karatan O, Ertuğ AE. Remission of nephrotic syndrome after removal of localized Castleman’s disease.
Am J Kidney Dis 35:2000;1207–1211.
12. Chan TM, Cheng IK, Wong KL, Chan KW. Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman’s disease).
Nephron 65:1993;628–632.
13. McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
Clin J Am Soc Nephrol 5:2010;2115–2121.
14. Lennon R, Singh A, Welsh GI, Coward RJ, Satchell S, Ni L, Mathieson PW, Bakker WW, Saleem MA. Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.
J Am Soc Nephrol 19:2008;2140–2149.
15. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
Nat Med 17:2011;952–960.